Finerenone-A New Frontier in Renin-Angiotensin-Aldosterone System Inhibition in Diabetic Kidney Disease

Affiliations

• ¹ Department of Medicine, Division of Nephrology, UHN, Toronto, Canada; Banting and Best Diabetes Centre, Toronto, Canada.
• ² Department of Medicine, Division of Nephrology, UHN, Toronto, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Banting and Best Diabetes Centre, Toronto, Canada.
• ³ Department of Medicine, Division of Nephrology, UHN, Toronto, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Department of Physiology, University of Toronto, Toronto, Ontario; Banting and Best Diabetes Centre, Toronto, Canada. Electronic address: david.cherney@uhn.ca.